XML 37 R8.htm IDEA: XBRL DOCUMENT v3.23.1
Restatement of Previously Issued Financial Statements
12 Months Ended
Dec. 31, 2022
Restatement of Previously Issued Financial Statements [Abstract]  
Restatement of Previously Issued Financial Statements

Note 2 - Restatement of Previously Issued Financial Statements

 

Subsequent to filing of its Form 20-F, the Company identified errors in its historical financial statements related to the accounting for the acquisition of Cheyi. The Company used negotiated and agreed price of the Company’s ordinary shares, which is $4.00 per shares, for the recognition of the valuation of shares issued in the acquisition and purchase consideration. However, the Company should have used the quoted trading price of the Company’s ordinary shares on the date of acquisitions for the valuation of shares issued in the acquisition and purchase consideration.

 

The tables below summarize the effects of the restatement on the consolidated balance sheets as of December 31, 2021. There was no impact from this restatement on the years ended prior to December 31, 2021.

 

    As of December 31, 2021  
    As Previously
Reported
    Restatement
Adjustment
    As Restated  
Balance Sheet                  
Goodwill   $ 20,152,890     $ (5,995,320 )   $ 14,157,570  
Total non-current asset     42,740,835       (5,995,320 )     36,745,515  
Total assets   $ 82,349,986     $ (5,995,320 )   $ 76,354,666  
                         
Additional paid-in capital   $ 41,792,071     $ (5,995,320 )   $ 35,796,751  
Total shareholders’ equity   $ 47,668,934     $ (5,995,320 )   $ 41,673,614